Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2026 · third_quarter · Q3
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2026 · second_quarter · Q2
Source: Senate LDA
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2026 · first_quarter · 1A
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2026 · first_quarter · Q1
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2025 · fourth_quarter · Q4
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2025 · third_quarter · Q3
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2025 · second_quarter · Q2
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2025 · first_quarter · Q1
healthcare and health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2024 · fourth_quarter · Q4
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2024 · third_quarter · Q3
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2024 · second_quarter · Q2
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2024 · first_quarter · Q1
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2023 · fourth_quarter · Q4
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2023 · third_quarter · Q3
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2023 · second_quarter · Q2
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2023 · first_quarter · Q1
healthcare
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2022 · fourth_quarter · Q4
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2022 · third_quarter · 3A
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2022 · third_quarter · Q3
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2022 · second_quarter · Q2
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2022 · first_quarter · Q1
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2021 · fourth_quarter · Q4
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2021 · third_quarter · Q3
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2021 · second_quarter · Q2
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2021 · first_quarter · Q1
health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · second_quarter · 2A
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · second_quarter · 2A
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · fourth_quarter · Q4
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · third_quarter · Q3
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · second_quarter · Q2
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2020 · first_quarter · Q1
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2019 · fourth_quarter · Q4
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2019 · third_quarter · Q3
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2019 · second_quarter · Q2
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2019 · first_quarter · Q1
Health care
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2018 · fourth_quarter · Q4
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2018 · third_quarter · Q3
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2018 · second_quarter · Q2
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2018 · first_quarter · Q1
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2017 · fourth_quarter · Q4
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2017 · third_quarter · Q3
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2017 · second_quarter · Q2
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2017 · first_quarter · Q1
Diabetes, Obesity, NIH funding, Physician Reimbursement, Healthcare Quality Measures, Endocrine-Disrupting Chemicals
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2016 · fourth_quarter · Q4
Biomedical Research Funding, Endocrinologists Workforce Issues, Minority Health Disparities, Stem Cell Research, Obesity Issues, Hormone Abuse/Misuse, Copyright Protection, Use of Animals in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2016 · third_quarter · Q3
Biomedical Research Funding, Endocrinologists Workforce Issues, Minority Health Disparities, Stem Cell Research, Obesity Issues, Hormone Abuse/Misuse, Copyright Protection, Use of Animals in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2016 · second_quarter · Q2
Biomedical Research Funding, Endocrinologists Workforce Issues, Minority Health Disparities, Stem Cell Research, Obesity Issues, Hormone Abuse/Misuse, Copyright Protection, Use of Animals in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
ENDOCRINE SOCIETY via ENDOCRINE SOCIETY
2016 · first_quarter · Q1
Biomedical Research Funding, Endocrinologists Workforce Issues, Minority Health Disparities, Stem Cell Research, Obesity Issues, Hormone Abuse/Misuse, Copyright Protection, Use of Animals in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE